Fact check: Dr. Vin Gupta reported that a personalized mRNA vaccine for pancreatic cancer is showing lasting results.

Verdict: verified — Trust Score 100/100

This post is authentic and accurately describes a major medical breakthrough reported in April 2026. Dr. Vin Gupta's statements align perfectly with data presented by Memorial Sloan Kettering researchers at the AACR 2026 conference, confirming that nearly 90% of vaccine responders in a small trial survived for six years.

verified verification card — Trust Score 100/100
Platform
instagram
Source author
meidastouchsee all fact-checks of this account
Original post
https://www.instagram.com/reel/DXUWowxlV7Z/?igsh=N3ZzbWR4NzRmaHph
Verified on
April 28, 2026
Verification ID
5Rm29-svN1UJ4B5UIMrytw

Original content reviewed

Platform: INSTAGRAM Author: @meidastouch --- Caption/Description --- Dr. Vin Gupta tells us about a promising breakthrough: a personalized mRNA vaccine for pancreatic cancer is showing lasting results, with nearly all patients who responded still alive six years later. Early trial data is encouraging—but researchers caution more study is needed. --- Audio Transcript (What was said) --- And a bit of good news, MRNA vaccines for pancreatic cancer appear to actually do what we were hopeful they would do, which is help people live longer. This is a very difficult diagnosis. It's hard for people to live for longer than five years after a diagnosis. It's just very, very challenging. And MRNA vaccines for pancreatic cancer are showing us that perhaps the future is bright for these patients. Those patients, and these are small studies right now, that receive this vaccine actually amount an immune response. So their immune system creates cells that attacks the pancreatic cancer and frankly helps them live a lot longer. These are early studies, but the signal here is promising. And it's a reason why HHS and RFK Jr. should be reversing their cuts to MRNA vaccine research and accelerating the adoption of these new therapies and trials, not cutting them back. --- On-Screen Text (OCR) --- GOOD NEWS FROM DR. GUPTA: mRNA Vaccines helping pancreatic cancer patients live longer VACCCINES FOR PANCREATIC Pancreatic cancer mRNA vaccine shows lasting results in an early trial Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later. Dr. Vin Gupta --- GOOD NEWS FROM DR. GUPTA: mRNA Vaccines helping pancreatic cancer patients live longer PEOPLE TO LIVE Dr. Vin Gupta --- GOOD NEWS FROM DR. GUPTA: mRNA Vaccines helping pancreatic cancer patients live longer FIVE YEARS AFTER DIAGNOSIS. Dr. Vin Gupta --- GOOD NEWS FROM DR. GUPTA: mRNA Vaccines helping pancreatic canc

Claims analyzed (3)

  1. verified: Dr. Vin Gupta reported that a personalized mRNA vaccine for pancreatic cancer is showing lasting results.
    Dr. Vin Gupta, a medical contributor, shared this update on social media and news platforms following the AACR 2026 conference where the data was presented.
  2. verified: Nearly all patients who responded to the personalized vaccine are still alive six years later.
    Follow-up data from the Phase 1 trial presented in April 2026 showed that 7 out of 8 (87.5%) patients who mounted an immune response to the vaccine were still alive after six years.
  3. verified: Scientists caution that more research is needed.
    The principal investigator, Dr. Vinod Balachandran, and other experts noted that while the results are promising, the study was small (16 patients) and requires confirmation in larger Phase 2 and 3 trials.

Sources consulted (8)

Related verifications

AI-generated analysis. Not a substitute for professional fact-checking.